e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Respiratory epidemiology: genetics and modifiable risk factors
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Associations of different serum 25(OH)D levels to parameters of respiratory health in COPD patients
L. J. P. Persson, M. Voll-Aanerud, P. Bakke, J. A. Hardie, P. S. Hiemstra, T. M. Eagan (Bergen, Norway; Leiden, Netherlands)
Source:
Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors
Session:
Respiratory epidemiology: genetics and modifiable risk factors
Session type:
Thematic Poster Session
Number:
1011
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. J. P. Persson, M. Voll-Aanerud, P. Bakke, J. A. Hardie, P. S. Hiemstra, T. M. Eagan (Bergen, Norway; Leiden, Netherlands). Associations of different serum 25(OH)D levels to parameters of respiratory health in COPD patients. Eur Respir J 2011; 38: Suppl. 55, 1011
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Gender differences in plasma biomarkers levels in patients with COPD
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Serum sex hormone levels in COPD patients and its relation with hypoxaemia and pulmonary functions
Source: Eur Respir J 2001; 18: Suppl. 33, 213s
Year: 2001
The relationship between respiratory muscle dysfunction and serum vitamin D level in COPD patients
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021
Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients.
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
Determinants of serum leptin and adiponectin levels in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 59s
Year: 2005
Relation of low serum lipid levels with coronary atherosclerosi in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 662s
Year: 2006
Plsama leptin and TNF-a relation to nutritional parameters and elevated cost of ventilation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 36s
Year: 2006
The relationship between the serum YKL-40 level and severity of asthma
Source: Annual Congress 2012 - Asthma management
Year: 2012
Relationship between vitamin A and inflammation in the sputum and serum of smokers and COPD patients
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Association of serum bilirubin and clinical outcomes in COPD
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019
Relationship between COPD health outcome and lower socioeconomic status in Tunisian patients
Source: International Congress 2017 – Latest insights into the management of chronic lung diseases
Year: 2017
Serum vitamin D level is associated with emphysema progression in male patients with COPD
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Health status measurement in COPD patients. Correlations with dyspnea and physiologic outcomes
Source: Eur Respir J 2005; 26: Suppl. 49, 515s
Year: 2005
Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory
Source: Annual Congress 2013 –COPD treatment
Year: 2013
The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Serum vitamin D3 level correlates with FEV1 in patients with advanced COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
The interrelation between inflammation markers and protease-antiprotease status in blood serum in patients with stable COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Serum TGF-β level in patients with different stages of stable COPD
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Total serum bilirubin levels are not related to the severity of COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Measurement of serum total antioxidant status in patients with community acquired pneumonia: correlation with the severity of the disease
Source: Eur Respir J 2002; 20: Suppl. 38, 283s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept